CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
14356-65-1 | | octadecanoic acid, 10-hydroxy-, triester with glycerol, tris(hydrogen sulfate), | | | | |
14356-96-8 | | guanosine 5'-(tetrasodium triphosphate) | | | | |
1435615-18-1 | 4-(4-(3-(1h-吡唑-4-基)吡唑并[1,5-a]嘧啶-6-基)苯基)吗啉 | 4-(4-(3-(1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenyl)morpholine | C19H18N6O | 346.39 | | |
143564-89-0 | 苄基(2R,4R)-4-甲基-5-氧代-2-苯基-1,3-噁唑烷-3-羧酸 | benzyl (2R,4R)-4-methyl-5-oxo-2-phenyl-1,3-oxazolidine-3-carboxylate | C18H17NO4 | 311.33 | | |
143566-22-7 | | oxirane, ethyl-, polymer with oxirane, mono[2-(2-methoxyethoxy)ethyl] ether | | | | |
14357-08-5 | N6-Ethyladenosine | | C12H17N5O4 | 295.29 | | |
14357-21-2 | | dimethyldioctadecylammonium | | | | |
14357-44-9 | | propanal,2-methyl-2-(methylsulfonyl)-,oxime | C5H11NO3S | 165.21 | | |
14357-70-1 | | 1-alpha-h,5-alpha-h-tropan-3-alpha-ol, (+)-2-methyl-2-phenylhydracrylate ester, | | | | |
14357-76-7 | | 18,19-dihydroetorphine | | | | |
14357-78-9 | | diprenorphine | | | | |
14357-82-5 | | carbamic acid, (hydroxymethyl)-, 6-chloro-3,4-xylyl ester | | | | |
14357-93-8 | | 6,6'-(terephthaloyldiimino)bis(1-methyl-quinoliniu di-p-toluenesulfonate | | | | |
14357-94-9 | | 3-allyl-5-(1-cyclohexen-1-yl)-1,5-dimethyl-barbituric aci | | | | |
1435710-71-6 | 1H-1,2,4-三唑,1,1-(1,4-亚苯基)双 - | 1H-1,2,4-Triazole,1,1-(1,4-phenylene)bis- | C10H8N6 | 212.21 | | 454.8±55.0℃(Predicted) |
143572-49-0 | | 3-benzoyl-1-ethyl-6-methyl-2(1h)-pyridinon | | | | |
143572-55-8 | | 1,6-dimethyl-3-(4-methylbenzoyl)-4-phenyl-2(1h)-pyridinon | | | | |
143572-56-9 | | 3-(4-chlorobenzoyl)-1,6-dimethyl-4-phenyl-2(1h)-pyridinon | | | | |
143572-60-5 | | methyl 4-(bromomethyl)-2-chlorobenzoate | C9H8BrClO2 | 263.52 | | |
1435727-11-9 | 6β-naltrexol-d3 solution | | C20H22D3NO4 | 346.4 | | |
1435727-97-1 | (S)-Duloxetine D3 hydrochloride | Duloxetine D3 hydrochloride | C18H17D3ClNOS | 336.89 | | |
1435728-64-5 | 帕罗西汀-d6马来酸盐标准液 溶液 | paroxetine-d6 maleate solution | | | | |
1435753-36-8 | 2-(4-溴-1H-吡唑-1-基)乙基氨基甲酸叔丁酯 | Tert-Butyl (2-(4-bromo-1h-pyrazol-1-yl)ethyl)carbamate | C10H16BrN3O2 | 290.16 | | |
143577-46-2 | (R)-四氢-3h-吡咯并[1,2-c][1,2,3]恶噻唑-1,1-二氧化物 | (R)-tetrahydro-3h-pyrrolo[1,2-c][1,2,3]oxathiazole 1,1-dioxide | C5H9NO3S | 163.20 | | |
143578-51-2 | | 10h-dibenz(b,e)iodinium, 3,7-bis(dimethylamino)-, salt with n,n'-1,2-ethanediyl | | | | |
1435782-38-9 | Tapentadol-d3 hydrochloride (CRM) | | C14H20D3NO • HCl | 260.8 | | |
1435784-14-7 | 洛美曲索水合物 | Lometrexol hydrate | C21H27N5O7 | 461.47 | | |
1435784-43-2 | | (5R)-5-(1h-indol-3-ylmethyl)-2,2,3-trimethyl-4-imidazolidinone monohydrochloride | | | | |
1435784-65-8 | | (1R,8S,9S)-bicyclo[6.1.0]non-4-yn-9-ylmethyl n-{2-[(2-aminoethyl)disulfanyl]ethyl}carbamate | | | | |
1435786-04-1 | Rapastinel Trifluoroacetate | | C20H32F3N5O8 | 527.49 | | |
143579-10-6 | | quinazolinium, 3,4-dihydro-3-(4-chlorophenyl)-1-((3,4-dimethoxyphenyl)methyl)-2 | | | | |
143579-11-7 | | n-phenyl-4-morpholineacetamid monohydrochloride | | | | |
143579-12-8 | | n-(2-hydroxyphenyl)-4-morpholineacetamid monohydrochloride | | | | |
143579-13-9 | | n-(2-methylphenyl)-4-morpholineacetamid monohydrochloride | | | | |
143579-14-0 | | n-(2-ethylphenyl)-4-morpholineacetamid monohydrochloride | | | | |
143579-15-1 | | n-(2-methoxyphenyl)-4-morpholineacetamid monohydrochloride | | | | |
143579-16-2 | | n-(2-fluorophenyl)-4-morpholineacetamid monohydrochloride | | | | |
143579-17-3 | | n-(2-bromophenyl)-4-morpholineacetamid monohydrochloride | | | | |
143579-18-4 | | n-(2-iodophenyl)-4-morpholineacetamid monohydrochloride | | | | |
143579-19-5 | | n-(2-nitrophenyl)-4-morpholineacetamid monohydrochloride | | | | |
14358-33-9 | | h-dl-asp(ome)-ome . hcl | C6H11NO4.HCl | 197.61 | | 223°C at 760 mmHg |
14358-46-4 | | | | | | |
14358-50-0 | | alpha-(1-((1-methyl-2-phenoxyethyl)amino)ethyl)-vanillyl alcoho hydrochlori | | | | |
1435803-73-8 | 2-氨基-n-((3-苄基-1,2,4-噁二唑-5-基)甲基)乙酰胺盐酸盐 | 2-amino-n-((3-benzyl-1,2,4-oxadiazol-5-yl)methyl)acetamide hydrochloride | | | | |
1435803-86-3 | 3-氨基-n-((3-异丙基-1,2,4-噁二唑-5-基)甲基)丙酰胺盐酸盐 | 3-amino-n-((3-isopropyl-1,2,4-oxadiazol-5-yl)methyl)propanamide hydrochloride | | | | |
1435804-09-3 | 3-氨基-n-((3-苯基-1,2,4-噁二唑-5-基)甲基)丙酰胺盐酸盐 | 3-amino-n-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)propanamide hydrochloride | | | | |
1435804-19-5 | 3-(3-(呋喃-2-基)-1,2,4-噁二唑-5-基)丙-1-胺盐酸盐 | 3-(3-(furan-2-yl)-1,2,4-oxadiazol-5-yl)propan-1-amine hydrochloride | | | | |
1435804-21-9 | 3-(3-(2-氯-6-氟苯基)-1,2,4-噁二唑-5-基)丙-1-胺盐酸盐 | 3-(3-(2-chloro-6-fluorophenyl)-1,2,4-oxadiazol-5-yl)propan-1-amine hydrochloride | | | | |
1435804-37-7 | 2-(3-(吡啶-3-基)-1,2,4-噁二唑-5-基)乙-1-胺二盐酸盐 | 2-(3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)ethan-1-amine dihydrochloride | | | | |
1435804-43-5 | 2-氨基-n-(2-(3-苯基-1,2,4-噁二唑-5-基)乙基)乙酰胺盐酸盐 | 2-amino-n-(2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl)acetamide hydrochloride | | | | |